|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Natural product or derivative |
| Approved drug? | Yes (source: FDA (1990)) |
IUPAC Name ![]() |
| (7S,9S)-9-acetyl-7-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5174 | idarubicin |
Synonyms ![]() |
| Idamycin® |
| IMI-30 |
| Zavedos® |
Database Links ![]() |
|
| CAS Registry No. | 58957-92-9 |
| ChEBI | CHEBI:42068 |
| ChEMBL Ligand | CHEMBL1117 |
| DrugBank Ligand | DB01177 |
| PubChem CID | 42890 |
| RCSB PDB Ligand | DM5 |
| Search Google for chemical match using the InChIKey | XDXDZDZNSLXDNA-TZNDIEGXSA-N |
| Search Google for chemicals with the same backbone | XDXDZDZNSLXDNA |
| Search PubMed clinical trials | idarubicin |
| Search PubMed titles | idarubicin |
| Search PubMed titles/abstracts | idarubicin |
| Wikipedia | Idarubicin |
| Comments |
| Idarubicin is an anthracycline type antineoplastic drug. |